ACADIA Pharmaceuticals Inc ACAD
Morningstar Growth Grade: A
Projected Annual Return: 23.20%
6/18/2021 price: $25.85
Company Profile
Business Description
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Contact12830 El Camino Real, Suite 400
San Diego, CA, 92130
San Diego, CA, 92130
T +1 858 558-2871
SectorHealthcare
IndustryBiotechnology
Most Recent EarningsMar 31, 2021
Fiscal Year EndDec 31, 2021
Stock TypeSpeculative Growth
Employees640
No comments:
Post a Comment